Tag: biosimilar coding
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
How Hypocalcemia and Hypomagnesemia Influence Each Other
Oct, 3 2025
Batch Variability and Bioequivalence: What the Acceptable Limits Really Mean
Feb, 2 2026
How and Where to Buy Furosemide Online: A Safe Guide for 2026
Jul, 23 2026
Levodopa and Antipsychotics: How Opposing Dopamine Effects Worsen Symptoms
Dec, 18 2025
Top 5 Metformin Alternatives in 2025 for Diabetes Management
Jan, 5 2025